HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nobuyuki Okamura Selected Research
Nobuyuki Okamura Research Topics
Disease
70
Alzheimer Disease (Alzheimer's Disease)
12/2023 - 11/2002
25
Cognitive Dysfunction
10/2022 - 03/2002
20
Dementia (Dementias)
10/2022 - 07/2009
18
Amyloid Plaque
08/2023 - 01/2004
16
Gliosis
12/2023 - 01/2018
9
Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2022 - 01/2017
8
Parkinson Disease (Parkinson's Disease)
06/2023 - 09/2009
7
Neurodegenerative Diseases (Neurodegenerative Disease)
12/2023 - 11/2009
7
Tauopathies
01/2021 - 09/2013
6
Disease Progression
12/2018 - 06/2014
4
Corticobasal Degeneration
01/2021 - 09/2013
4
Atrophy
01/2019 - 05/2014
4
Constipation
01/2019 - 01/2011
4
Proteostasis Deficiencies
01/2018 - 11/2009
3
Multiple System Atrophy
01/2022 - 06/2010
3
Parkinsonian Disorders (Parkinsonism)
01/2019 - 05/2004
3
Sleepiness
01/2019 - 03/2002
2
Neuroinflammatory Diseases
01/2023 - 08/2022
2
Primary Progressive Aphasia
09/2018 - 01/2018
2
Frontotemporal Dementia (Semantic Dementia)
01/2018 - 05/2014
2
Normal Pressure Hydrocephalus
01/2018 - 09/2015
2
Body Weight (Weight, Body)
03/2017 - 12/2002
2
Amyloidosis
01/2012 - 05/2010
1
Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2024
1
Venous Thrombosis (Deep-Vein Thrombosis)
01/2024
1
Brain Diseases (Brain Disorder)
01/2023
1
Pathologic Processes
01/2023
1
Lewy Body Disease (Lewy Body Dementia)
01/2023
1
Chronic Renal Insufficiency
01/2021
1
Stroke (Strokes)
10/2020
1
Cerebellar Ataxia (Dysmetria)
01/2019
1
Prodromal Symptoms
01/2019
1
REM Sleep Behavior Disorder
01/2019
1
Inflammation (Inflammations)
12/2018
1
Primary Progressive Nonfluent Aphasia (Progressive Nonfluent Aphasia)
01/2018
1
Movement Disorders (Movement Disorder)
01/2017
1
Dysbiosis
01/2016
Drug/Important Bio-Agent (IBA)
46
Amyloid (Amyloid Fibrils)
IBA
01/2024 - 01/2004
24
THK5351
IBA
08/2022 - 02/2016
15
Monoamine Oxidase (MAO)
IBA
12/2023 - 01/2018
15
Biomarkers (Surrogate Marker)
IBA
10/2022 - 11/2002
10
Proteins (Proteins, Gene)
FDA Link
01/2023 - 11/2009
10
tau Proteins (tau Protein)
IBA
01/2021 - 11/2005
7
Amyloid beta-Peptides
IBA
03/2022 - 01/2004
7
Donepezil (Aricept)
FDA Link
Generic
03/2016 - 03/2006
7
Benzoxazoles
IBA
11/2014 - 03/2004
7
2- (2- (2- dimethylaminothiazol- 5- yl)ethenyl)- 6- (2- (fluoro)ethoxy)benzoxazole
IBA
08/2013 - 04/2007
5
daiokanzoto
IBA
01/2019 - 01/2011
5
Ligands
IBA
01/2017 - 11/2009
4
2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)
IBA
01/2019 - 09/2013
4
Histamine Antagonists (Antihistamines)
IBA
01/2019 - 12/2010
4
Histamine (Histamine Dihydrochloride)
FDA Link
01/2010 - 03/2006
3
alpha-Synuclein
IBA
06/2023 - 09/2009
3
quinoline
IBA
10/2022 - 11/2005
3
Synucleins
IBA
01/2019 - 11/2009
3
2- (4- aminophenyl)- 6- (2- fluoroethoxy)quinoline
IBA
05/2014 - 04/2011
2
5- (6- hydroxy- 4- oxo- 2- thioxo- 1,2,3,4- tetrahydroxy- 5- pyrimidinyl)- 2,4- pentadienylidene- 2- thioxodihydro- 4,6(1H,5H)- pyrimidinedione
IBA
08/2023 - 01/2011
2
Protein Aggregates
IBA
08/2023 - 01/2018
2
DNA-Binding Proteins (DNA Binding Protein)
IBA
01/2023 - 01/2018
2
Loratadine (Alavert)
FDA Link
01/2019 - 03/2011
2
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
01/2018 - 08/2013
2
Glucose (Dextrose)
FDA Link
Generic
11/2017 - 12/2002
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
11/2017 - 12/2002
2
Cholinesterase Inhibitors (Anticholinesterases)
IBA
03/2016 - 01/2012
2
Sennosides (Senokot)
IBA
01/2016 - 01/2011
2
benzimidazole
IBA
02/2014 - 11/2005
2
AD 20 (AD-20)
IBA
01/2012 - 07/2011
2
Cholinergic Agents (Cholinergics)
IBA
01/2012 - 04/2008
2
florbenazine F 18
IBA
01/2012 - 07/2011
2
Hypnotics and Sedatives (Sedatives)
IBA
07/2011 - 12/2010
2
Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)
IBA
07/2011 - 02/2010
2
Chlorpheniramine (Chlorphenamine)
FDA Link
Generic
03/2011 - 03/2002
2
Prion Proteins
IBA
05/2010 - 11/2009
2
6- (2- fluoroethoxy)- 2- (2- (4- methylaminophenil)ethenyl)benzoxazole
IBA
03/2007 - 03/2004
1
2- (4,5- dihydro- 1H- imidazol- 2- yl)- 1- methyl- 1H- indole
IBA
12/2023
1
Deuterium
IBA
12/2023
1
Selegiline (E250)
FDA Link
Generic
12/2023
1
Iron
IBA
06/2023
1
Glial Fibrillary Acidic Protein
IBA
01/2023
1
Lipopolysaccharides
IBA
01/2023
1
Apolipoproteins
IBA
01/2023
1
Peptides (Polypeptides)
IBA
01/2023
1
Apolipoproteins E (ApoE)
IBA
01/2023
1
Indican
IBA
01/2021
1
Enzymes
IBA
01/2021
1
indole
IBA
01/2021
1
Laxatives
IBA
01/2019
1
desloratadine (Aerius)
FDA Link
Generic
01/2019
1
Copper
IBA
01/2018
1
Polyvinyl Chloride (PVC)
IBA
01/2018
1
Metals
IBA
01/2018
1
Ions
IBA
01/2018
1
Protein Isoforms (Isoforms)
IBA
01/2018
1
Zinc
IBA
01/2018
1
6- ((3- fluoro- 2- hydroxy)propoxy)- 2- (4- methylaminophenyl)quinoline
IBA
01/2017
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2016
1
Glucosidases
IBA
01/2016
Therapy/Procedure
9
Therapeutics
08/2023 - 01/2004
3
Intravenous Administration
08/2023 - 01/2011
2
Kampo Medicine (Kampo)
01/2011 - 01/2011